Nlx Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.40 M
- Company Age 1 Year 10 Months
- Last Filing with ROC 31 Mar 2024
About Nlx Life Sciences
Nlx Life Sciences Private Limited (NLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 March 2023 (One year and ten months 16 days old ). Its registered office is in Sangli, Maharashtra, India.
The Company is engaged in the Paper Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.40 M, as per Ministry of Corporate Affairs (MCA) records.
Company Details
-
Location
Sangli, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U21009PN2023PTC218828
-
Company No.
218828
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Mar 2023
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Nlx Life Sciences?
Board Members (6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajay Chouthai
|
Director | 20-Mar-2023 | Current |
|
Sandeep Deval
|
Director | 20-Mar-2023 | Current |
|
Preeti Deval
|
Director | 20-Mar-2023 | Current |
|
Sanika Prani
|
Director | 20-Mar-2023 | Current |
|
Kavita Chouthai
|
Director | 20-Mar-2023 | Current |
|
Bhaskar Prani
|
Director | 20-Mar-2023 | Current |
Financial Performance of Nlx Life Sciences.
Enhance accessibility to Nlx Life Sciences's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nlx Life Sciences?
Unlock access to Nlx Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Nishakarsha Referral Lab Private LimitedAjay Chouthai is a mutual person
-
Unique Institute Of Critical Care Llp
Sanika Prani is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nlx Life Sciences?
Unlock and access historical data on people associated with Nlx Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nlx Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nlx Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.